Thyrocare Technologies Ltd Share Price (THYROCARE)
as on
| Source : NSE
Thyrocare Technologies Ltd Stock Performance
as on August 26, 2025 at 4:01 PM IST
Day's Low
Day's High
₹1,255.7₹1,329.7
0.88%
Downside
4.96%
Upside
52 Week's Low
52 Week's High
₹658₹1,43548.06%
Downside
13.27%
Upside
| Market Stats | |
| Previous Close | ₹1,265.30 |
| Open | ₹1,269.70 |
| Volume | 2.08L |
| Upper Circuit | ₹1,518.30 |
| Lower Circuit | ₹1,012.30 |
| Day's Low | ₹1,255.7 |
| Day's High | ₹1,329.7 |
| 52 Week Low | ₹658 |
| 52 Week High | ₹1,435 |
| Returns % | |
| 1 Month Return | + 1.65 % |
| 3 Month Return | + 25.01 % |
| 1 Year Return | + 40.46 % |
| 3 Year Return | + 107.26 % |
| 5 Year Return | + 68.11 % |
Thyrocare Technologies Ltd Stock Fundamentals & Key Indicators
Check Thyrocare Technologies Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹6,713.87 Cr
Return on Equity (ROE)
18.23
PE Ratio (TTM)
63.06
Return on capital employed (ROCE)
27.26
Industry PE ratio
53.56
Beta (LTM)
0.32
P/B Ratio
7.46
Dividend Yield
3.09
PEG Ratio
11.66
Quarterly Earnings Growth YOY
59.94
EPS (TTM)
17.13
Sector
Healthcare
Book Value
92.81
Technical Analysis
Bullish
View Technical Analysis
Thyrocare Technologies Ltd Stock's Interest Amongst Investors
Thyrocare Technologies Ltd Stock Valuation
Track how Thyrocare Technologies Ltd P/E has moved over time to understand its valuation trends.
Thyrocare Technologies Ltd in the last 5 years
Lowest (18.71x)
June 23, 2022
Industry (53.56x)
August 26, 2025
Today (63.06x)
August 26, 2025
Highest (91.79x)
October 27, 2020
Today’s Price to Earnings Ratio: 63.06x
Thyrocare Technologies Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Thyrocare Technologies Ltd.
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Thyrocare Technologies Ltd. Average target price of ₹1355
Source: S&P Global Market Intelligence
Thyrocare Technologies Ltd Share Price Target
Get share price movements and forecasts by analysts on Thyrocare Technologies Ltd.
Thyrocare Technologies Ltd price forecast by 2 analysts
Upside of6.95%
High
₹1460
Target
₹1355.00
Low
₹1250
Thyrocare Technologies Ltd target price ₹1355, a slight upside of 6.95% compared to current price of ₹1266.9. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Thyrocare Technologies Ltd revenue growth forecast
Expected growth rate Q1, FY2027:44.06%
Forecast
Actual
Including amortisation and stock based compensations
Thyrocare Technologies Ltd EPS growth forecast
EPS estimate Q1, FY2027:88.77%
Forecast
Actual
Source: S&P Global Market Intelligence
Thyrocare Technologies Ltd Financial Results
Get the annual and quarterly financial summary of Thyrocare Technologies Ltd, including revenue, profit, loss and more.
Thyrocare Technologies Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Thyrocare Technologies Ltd.
Thyrocare Technologies Ltd Earnings Results
Thyrocare Technologies Ltd’s net profit jumped 61.07% since last year same period to ₹38.93Cr in the Q1 2025-2026. On a quarterly growth basis, Thyrocare Technologies Ltd has generated 79.4% jump in its net profits since last 3-months.
Read More about Earnings ResultsThyrocare Technologies Ltd Dividends April,2025
In the quarter ending March 2025, Thyrocare Technologies Ltd has declared dividend of ₹21.00 per share on 23 Apr 2025 - translating a dividend yield of 3.08%.
Read More about Dividends
Indices Featuring Thyrocare Technologies Ltd Stock
Check stock indices that include Thyrocare Technologies Ltd.
Thyrocare Technologies Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Thyrocare Technologies Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.06% | 0.00 | |
| Foreign Institutions | 3.23% | 34.18 | |
| Mutual Funds | 12.66% | ||
| Retail Investors | 11.17% | ||
| Others | 1.88% |
Thyrocare Technologies Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Thyrocare Technologies Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 6,713.87 | 13.62% | 0.53 | 90 | 687 | |
| BUY | 10,364.95 | 12.54% | 0.65 | 143 | 704 | |
| BUY | 11,189.38 | 3.74% | 0.57 | 145 | 1,331 | |
| HOLD | 27,717.13 | 15.65% | 0.54 | 492 | 2,461 | |
| HOLD | 46,891.89 | 52.93% | 0.71 | 354 | 5,553 |
Thyrocare Technologies Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Thyrocare Technologies Ltd.
Thyrocare Technologies Reports Strong Q1 Earnings - 24 Jul, 2025
Thyrocare Technologies shares surged after reporting a 62% year-on-year increase in net profit to ₹38.06 crore and a 23% rise in revenue for Q1 FY26. The company also announced the appointment of a new CFO.Thyrocare Reports Strong Q1FY26 Financial Results - 23 Jul, 2025
Thyrocare Technologies announced robust Q1FY26 results, with a 62% YoY increase in net profit to ₹38.06 crore and a 23% rise in revenue to ₹193.03 crore. The company expanded its laboratory presence and improved margins, solidifying its position in India's diagnostic sector.
Insights on Thyrocare Technologies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 19.11 Cr → 38.93 Cr (in ₹), with an average increase of 28.1% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 2.41% to 3.23% in Jun 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 169.93 Cr → 197.93 Cr (in ₹), with an average increase of 7.3% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, THYROCARE stock has moved up by 74.7%
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 69.7% return, outperforming this stock by 29.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 71.06% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 216.5% return, outperforming this stock by 109.2%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 11.56% to 11.17% in Jun 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 12.97% to 12.66% in Jun 2025 quarter
About Thyrocare Technologies Ltd
Revenue: ₹193.03Cr as on June 2025 (Q1 FY26)
Net Profit: ₹38.29Cr as on June 2025 (Q1 FY26)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
| Organisation | Thyrocare Technologies Ltd |
| Headquarters | Navi Mumbai |
| Industry | Healthcare |
| CEO | Rahul Guha |
| E-voting on shares | Click here to vote |
Mutual Funds that own Thyrocare Technologies Ltd Stock
Check out the Mutual Funds with significant holdings in Thyrocare Technologies Ltd.
FAQs
What is Thyrocare Technologies Ltd share price today?
Thyrocare Technologies Ltd share price today stands at ₹1266.9, Open: ₹1269.7, Previous Close: ₹1265.3, High: ₹1329.7, Low: ₹1255.7, 52 Week High: ₹1435, 52 Week Low: ₹658 as on .
How to buy Thyrocare Technologies Ltd shares ?
To buy Thyrocare Technologies Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for THYROCARE or Thyrocare Technologies Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Thyrocare Technologies Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Thyrocare Technologies Ltd?
Today's traded volume of Thyrocare Technologies Ltd is 2.08L. Which means that 2.08L shares of Thyrocare Technologies Ltd were bought and sold on the stock market during today's trading session.
What is Thyrocare Technologies Ltd's market cap today?
Today's market capitalisation of Thyrocare Technologies Ltd is ₹6,713.87 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Thyrocare Technologies Ltd?
Thyrocare Technologies Ltd’s 52 week high is ₹1435 and 52 week low is ₹658. The current share price of Thyrocare Technologies Ltd is ₹1266.9, which is -11.71% down from its 52 week high and 92.54% up from its 52 week low.